Summary
For Year 2026-27, Nectar Lifesciences reports the following shareholding: Total Promoters at 51.84%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.6%, Domestic Institutional Investors at 4.03%, and Retail at 43.52%. This breakdown provides a quick snapshot of ownership distribution for Nectar Lifesciences in 2026-27.
Nectar Lifesciences FAQs
As of 04-2026, the promoter shareholding in Nectar Lifesciences stands at 51.84% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Nectar Lifesciences is 0.6% and 4.03% respectively.
The retail shareholding of the Nectar Lifesciences is 43.52%.
Changes in shareholding patterns of Nectar Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Nectar Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Nectar Lifesciences Associated Pages
